If you were a Dividend.com Premium member, you would be seeing detailed dividend stock ratings information for Dr. Reddys Lab (RDY) in this space. Sign up for Dividend.com Premium today to gain access to ratings on over 2,000 dividend-paying stocks, exclusive members-only articles, historical dividend information, and more!
Dr. Reddy's Lab- (RDY)-was established in 1984 in Hyderabad, India, and is a global pharmaceutical company with proven research capabilities. Dr. Reddys conducts research in the areas of diabetes, obesity, cardiovascular diseases, anti-infectives and inflammation. The Indian based company produces finished dosage forms, active pharmaceutical ingredients and biotechnology products which are marketed globally, with focus on India, US, Europe and Russia.
* Stock price reflects previous day's closing price. All stock quotes on this website should be considered as having a 24-hour delay.
** Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.
OFFERS FROM OUR SPONSORS
DIRECT COMPETITORS
The following dividend stocks are considered direct competitors of Dr. Reddys Lab (RDY):
Add RDY to My Watchlist »
View Historical Dividend Data for RDY »
View a Sample of Our Stock Ratings
Company Profile
OFFERS FROM OUR SPONSORS
DIRECT COMPETITORS
RELATED COMPANIES
MORE RESEARCH
RSS Feeds